Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

706
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
706
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

892
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
892
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

776
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
776

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager.

Neuro-oncology·2026
Same author

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cells.

Cell reports. Medicine·2026
Same author

Can natural killer cells cure leukemia?

Leukemia·2026
Same author

HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo.

Cell reports. Medicine·2026
Same author

Dose-dependent activation of Syk and SHIP1 by LynA and LynB at steady state creates a threshold for macrophage signaling in the absence of receptor engagement.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 25, 2025

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells
13:18

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

18.1K

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A,

Anders W Matson, Rob H Hullsiek, Kate J Dixon

    Biorxiv : the Preprint Server for Biology
    |May 27, 2024
    PubMed
    Summary

    ADAM17 inhibition with Medi-1 enhances Interleukin-15 (IL-15)-driven Natural Killer (NK) cell proliferation. This novel strategy utilizes CD16A and CD137 to boost NK cell anti-tumor activity, offering therapeutic potential for cancer patients.

    More Related Videos

    Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
    09:54

    Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

    Published on: May 22, 2020

    3.5K
    High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
    13:59

    High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

    Published on: August 18, 2023

    2.0K

    Related Experiment Videos

    Last Updated: Jun 25, 2025

    Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells
    13:18

    Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

    Published on: December 29, 2012

    18.1K
    Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
    09:54

    Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

    Published on: May 22, 2020

    3.5K
    High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
    13:59

    High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

    Published on: August 18, 2023

    2.0K

    Area of Science:

    • Immunology
    • Cell Biology
    • Cancer Therapy

    Background:

    • Natural Killer (NK) cells are crucial for cancer immunotherapy, with their function enhanced by cytokines like Interleukin-15 (IL-15).
    • The protease ADAM17 acts as a negative feedback regulator, limiting NK cell activation by cleaving surface receptors.
    • Previous studies indicated that inhibiting ADAM17 can improve IL-15-mediated NK cell proliferation.

    Approach:

    • Human peripheral blood mononuclear cells (PBMCs) or enriched NK cells were cultured with IL-15 and various ADAM17-blocking antibodies, including Medi-1.
    • Flow cytometry, immunoblotting, and live cell imaging were employed to assess NK cell proliferation, signaling, and anti-tumor activity.
    • Engineered antibody variants were used to investigate the role of CD16A engagement in modulating NK cell responses.

    Key Points:

    • The ADAM17-blocking antibody Medi-1 significantly enhanced IL-15-induced NK cell activation and proliferation.
    • The activating Fcγ receptor CD16A was identified as critical for this enhancement, mediating antibody engagement and blocking ADAM17 shedding.
    • Medi-1 treatment synergized with IL-15 to upregulate CD137 on CD16A+ NK cells, promoting proliferation without inducing dysfunction.

    Conclusions:

    • CD16A and CD137 are key mediators of the enhanced NK cell activation and proliferation induced by Medi-1 in combination with IL-15.
    • Medi-1 represents a promising therapeutic strategy to augment NK cell-driven anti-tumor immunity.
    • This approach holds translational significance for enhancing the efficacy of NK cell therapies in cancer treatment.